At Mid City TMS, many patients seeking help for Depression describe a frustrating and exhausting pattern: persistent insomnia despite multiple medications. Difficulty falling asleep, staying asleep, or waking up too
Impact of Childhood Trauma and Depression in Adults: What It Means for Treatment-Resistant Cases
Major Depressive Disorder (MDD) is a complex and often chronic psychiatric condition affecting millions of individuals worldwide. The effects of MDD can sometimes be traced all the way back to
Can Loneliness Cause Suicidal Thoughts? What New Research Means for Mental Health Treatment
In recent years, loneliness has increasingly been recognized as a major public health concern. While it has long been associated with Depression and anxiety, new research suggests that loneliness may
Effects of Exercise on Depression: What New Research Means—and Where TMS Fits In
Depression is one of the most common and disabling health conditions worldwide. While medication and psychotherapy remain essential treatments, growing research continues to highlight the powerful role of lifestyle interventions
Depression and Cardiovascular Disease
Depression and cardiovascular disease (CVD) are two of the most pervasive and disabling health conditions globally—and mounting evidence shows that they are deeply interconnected. Heart disease continues to be the
Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe
Treatment-resistant Depression (TRD) poses a significant challenge in mental health care. Despite the availability of various antidepressant therapies, a substantial subset of patients fails to achieve response or remission, leading
Antidepressant Weight Gain: A Recent Study
In the landscape of mental health treatment, antidepressant medications play a crucial role in managing conditions like Depression. However, patients and clinicians often express concern about potential side effects, with
Can Spravato (Esketamine) Transform Treatment-Resistant Depression? Insights from a Recent Study
Treatment-resistant Depression (TRD) remains one of Psychiatry’s most complex clinical challenges. Standard antidepressants often fail to bring relief to approximately one-third of patients with Major depressive disorder (MDD). In this










